Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
4.79 USD -4.96% Intraday chart for Fate Therapeutics, Inc. -16.98% +28.07%
Mar. 21 Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC CI
Mar. 19 Fate Therapeutics Prices $100 Million Offering, Private Placement MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. FATE Stock
  4. News Fate Therapeutics, Inc.
  5. Official Publications